● About
Cornell Dots
Developer & Co-Inventor
Cornell Dots (C Dots) are a sub-10 nm silica nanoparticle platform engineered for cancer imaging, targeting, and therapeutic delivery developed by the Wiesner Materials Science Lab. The technology became a benchmark in translational nanomedicine: protected by multiple patents, supported by high-impact publications, advanced into human clinical trials, and forming the scientific foundation for Elucida Oncology, which raised $44M to develop C Dot-based cancer therapeutics.
Learn more
Awards, Features, Funders, Partners